BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3133691)

  • 21. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
    Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenously produced 5,6-dihydroxytryptamine may mediate the neurotoxic effects of para-chloroamphetamine.
    Commins DL; Axt KJ; Vosmer G; Seiden LS
    Brain Res; 1987 Sep; 419(1-2):253-61. PubMed ID: 2445423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
    Nielsen JA; Moore KE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemical effects of serotonin neurotoxins: an introduction.
    Fuller RW
    Ann N Y Acad Sci; 1978 Jun; 305():178-81. PubMed ID: 280249
    [No Abstract]   [Full Text] [Related]  

  • 26. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
    Reader TA; Gauthier P
    J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour.
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Eur J Pharmacol; 1980 Oct; 67(4):427-38. PubMed ID: 7449825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased sensitivity to intracerebroventricular infusion of serotonin and deaminated indoles after lesioning rat with dihydroxytryptamine.
    Warbritton JD; Stewart RM; Baldessarini RJ
    Brain Res; 1980 Feb; 183(2):355-66. PubMed ID: 6153283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 6-hydroxydopamine or 5,7-dihydroxy-tryptamine on the development of physical dependence on ethanol.
    Frye GD; Ellis FW
    Drug Alcohol Depend; 1977; 2(5-6):349-59. PubMed ID: 562250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
    Waller SB; Buterbaugh GG
    Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic pharmacology of p-chloroamphetamine, a serotonin agonist, in conscious rats.
    Alper RH; Lee C; Brody MJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):446-54. PubMed ID: 3681694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pre- and post-treatment with EXP 561 on the amine-depleting effects of p-chloroamphetamine and 6-hydroxydopamine in rats.
    Fuller RW; Snoddy HD
    Res Commun Chem Pathol Pharmacol; 1978 Sep; 21(3):457-65. PubMed ID: 705024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
    Kehne JH; McCloskey TC; Taylor VL; Black CK; Fadayel GM; Schmidt CJ
    J Pharmacol Exp Ther; 1992 Jan; 260(1):78-89. PubMed ID: 1731054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
    McElroy JF; Miller JM; Meyer JS
    J Pharmacol Exp Ther; 1984 Mar; 228(3):593-9. PubMed ID: 6323674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracortical 5,7-dihydroxytryptamine depletes brain serotonin concentrations without affecting spontaneous activity.
    Black RS; Robinson RG
    Pharmacol Biochem Behav; 1985 Feb; 22(2):327-31. PubMed ID: 3983223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p-Chloroamphetamine antagonism of cobaltous chloride-induced hypothermia in mice.
    Burke DH; Brooks JC; Ryan RP; Treml SB
    Eur J Pharmacol; 1979 Dec; 60(2-3):241-3. PubMed ID: 527659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo.
    Sharp T; Zetterström T; Christmanson L; Ungerstedt U
    Neurosci Lett; 1986 Dec; 72(3):320-4. PubMed ID: 3822235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
    Lorden JF; Oltmans GA; Dawson R; Callahan M
    Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of intraventricular p-chloroamphetamine and its analogues on cerebral 5-HT.
    Sherman A; Gál EM; Fuller RW; Molloy BB
    Neuropharmacology; 1975 Oct; 14(10):733-7. PubMed ID: 1196471
    [No Abstract]   [Full Text] [Related]  

  • 40. Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.
    Kiianmaa K; Attila LM
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):165-70. PubMed ID: 574195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.